Qube Research & Technologies (QRT)’s Maze Therapeutics MAZE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MAZE Stock Details MAZE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.03M	Buy	+134,950	New	+$5.96M	﹤0.01%	1779

Other funds holding MAZE

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Qube Research & Technologies (QRT)'s MAZE Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Maze Therapeutics (MAZE) in Q1 2026: 134,950 shares worth $4.03M. The stake represents ﹤0.01% of the portfolio and ranks #1779 among its holdings.

165 funds tracked by Wall St. Rank hold MAZE as of Q1 2026.

Qube Research & Technologies (QRT) held 134,950 shares of Maze Therapeutics worth $4.03M as of Q1 2026.
Maze Therapeutics was a new Qube Research & Technologies (QRT) position in Q1 2026.
Maze Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1779 holding.
165 funds tracked by Wall St. Rank held Maze Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.